• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多组学分析揭示了一型和二型子宫内膜癌中常见的失调通路。

A Multi-Omics Approach Revealed Common Dysregulated Pathways in Type One and Type Two Endometrial Cancers.

机构信息

Institute for Maternal and Child Health, IRCCS Institute for Maternal and Child Health-IRCCS Burlo Garofolo, 34137 Trieste, Italy.

Department of Pharmacy, University of Salerno, 84084 Salerno, Italy.

出版信息

Int J Mol Sci. 2023 Nov 7;24(22):16057. doi: 10.3390/ijms242216057.

DOI:10.3390/ijms242216057
PMID:38003247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10671314/
Abstract

Endometrial cancer (EC) is the most frequent gynecologic cancer in postmenopausal women. Pathogenetic mechanisms that are related to the onset and progression of the disease are largely still unknown. A multi-omics strategy can help identify altered pathways that could be targeted for improving therapeutical approaches. In this study we used a multi-omics approach on four EC cell lines for the identification of common dysregulated pathways in type 1 and 2 ECs. We analyzed proteomics and metabolomics of AN3CA, HEC1A, KLE and ISHIKAWA cell lines by mass spectrometry. The bioinformatic analysis identified 22 common pathways that are in common with both types of EC. In addition, we identified five proteins and 13 metabolites common to both types of EC. Western blotting analysis on 10 patients with type 1 and type 2 EC and 10 endometria samples confirmed the altered abundance of NPEPPS. Our multi-omics analysis identified dysregulated proteins and metabolites involved in EC tumor growth. Further studies are needed to understand the role of these molecules in EC. Our data can shed light on common pathways to better understand the mechanisms involved in the development and growth of EC, especially for the development of new therapies.

摘要

子宫内膜癌(EC)是绝经后妇女最常见的妇科癌症。与疾病发生和进展相关的发病机制在很大程度上仍不清楚。多组学策略可以帮助识别可能针对改善治疗方法的改变途径。在这项研究中,我们使用了一种多组学方法对四种 EC 细胞系进行分析,以鉴定 1 型和 2 型 EC 中常见的失调途径。我们通过质谱法分析了 AN3CA、HEC1A、KLE 和 ISHIKAWA 细胞系的蛋白质组学和代谢组学。生物信息学分析确定了 22 个与两种类型的 EC 都共同存在的常见途径。此外,我们还鉴定了两种类型的 EC 共有的 5 种蛋白质和 13 种代谢物。对 10 例 1 型和 2 型 EC 患者和 10 例子宫内膜样本进行的 Western blot 分析证实了 NPEPPS 的丰度改变。我们的多组学分析鉴定了参与 EC 肿瘤生长的失调蛋白和代谢物。需要进一步研究这些分子在 EC 中的作用。我们的数据可以阐明共同途径,以更好地理解 EC 发展和生长中涉及的机制,特别是为新疗法的开发提供思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/148e/10671314/31b2fabc7daf/ijms-24-16057-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/148e/10671314/77ce16ff3283/ijms-24-16057-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/148e/10671314/85dc803e6c89/ijms-24-16057-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/148e/10671314/26c967172213/ijms-24-16057-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/148e/10671314/f6bd72606c24/ijms-24-16057-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/148e/10671314/23d2bb10227e/ijms-24-16057-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/148e/10671314/c45f782ed003/ijms-24-16057-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/148e/10671314/31b2fabc7daf/ijms-24-16057-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/148e/10671314/77ce16ff3283/ijms-24-16057-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/148e/10671314/85dc803e6c89/ijms-24-16057-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/148e/10671314/26c967172213/ijms-24-16057-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/148e/10671314/f6bd72606c24/ijms-24-16057-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/148e/10671314/23d2bb10227e/ijms-24-16057-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/148e/10671314/c45f782ed003/ijms-24-16057-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/148e/10671314/31b2fabc7daf/ijms-24-16057-g007.jpg

相似文献

1
A Multi-Omics Approach Revealed Common Dysregulated Pathways in Type One and Type Two Endometrial Cancers.多组学分析揭示了一型和二型子宫内膜癌中常见的失调通路。
Int J Mol Sci. 2023 Nov 7;24(22):16057. doi: 10.3390/ijms242216057.
2
Phospho-DIGE Identified Phosphoproteins Involved in Pathways Related to Tumour Growth in Endometrial Cancer.磷酸化 DIGE 鉴定出与子宫内膜癌肿瘤生长相关通路中的磷酸化蛋白。
Int J Mol Sci. 2023 Jul 26;24(15):11987. doi: 10.3390/ijms241511987.
3
The Deep Proteomics Approach Identified Extracellular Vesicular Proteins Correlated to Extracellular Matrix in Type One and Two Endometrial Cancer.深度蛋白质组学方法鉴定了与 1 型和 2 型子宫内膜癌细胞外基质相关的细胞外囊泡蛋白。
Int J Mol Sci. 2024 Apr 24;25(9):4650. doi: 10.3390/ijms25094650.
4
Multi-Omic Profiling of Multi-Biosamples Reveals the Role of Amino Acid and Nucleotide Metabolism in Endometrial Cancer.多生物样本的多组学分析揭示氨基酸和核苷酸代谢在子宫内膜癌中的作用。
Front Oncol. 2022 Apr 29;12:861142. doi: 10.3389/fonc.2022.861142. eCollection 2022.
5
Recent Multiomics Approaches in Endometrial Cancer.最近在子宫内膜癌中的多组学方法。
Int J Mol Sci. 2022 Jan 22;23(3):1237. doi: 10.3390/ijms23031237.
6
Sirtuin 2 promotes cell stemness and MEK/ERK signaling pathway while reduces chemosensitivity in endometrial cancer.Sirtuin 2 促进了子宫内膜癌细胞的干性和 MEK/ERK 信号通路,同时降低了其对化疗的敏感性。
Arch Gynecol Obstet. 2022 Mar;305(3):693-701. doi: 10.1007/s00404-021-06216-2. Epub 2021 Sep 2.
7
Interactions between microRNA-200 family and Sestrin proteins in endometrial cancer cell lines and their significance to anoikis.miRNA-200 家族与 Sestrin 蛋白在子宫内膜癌细胞系中的相互作用及其对失巢凋亡的意义。
Mol Cell Biochem. 2019 Sep;459(1-2):21-34. doi: 10.1007/s11010-019-03547-2. Epub 2019 May 9.
8
Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis.代谢组学和脂质组学分析鉴定 RNA 编辑途径在子宫内膜癌发生中的作用。
Sci Rep. 2017 Aug 18;7(1):8803. doi: 10.1038/s41598-017-09169-2.
9
Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer.整合多组学分析和功能验证揭示 TTK 是子宫内膜癌中一种新型 EMT 激活物。
J Transl Med. 2023 Feb 25;21(1):151. doi: 10.1186/s12967-023-03998-8.
10
Profilin-1 is dysregulated in endometroid (type I) endometrial cancer promoting cell proliferation and inhibiting pro-inflammatory cytokine production.抑丝蛋白-1 在子宫内膜样(Ⅰ型)子宫内膜癌中失调,促进细胞增殖并抑制促炎细胞因子的产生。
Biochem Biophys Res Commun. 2020 Oct 22;531(4):459-464. doi: 10.1016/j.bbrc.2020.07.123. Epub 2020 Aug 14.

引用本文的文献

1
Integrated network pharmacology, molecular docking and experimental validation to investigate the mechanism of tannic acid in nasopharyngeal cancer.综合网络药理学、分子对接和实验验证以探究鞣酸在鼻咽癌中的作用机制。
Sci Rep. 2025 Feb 15;15(1):5645. doi: 10.1038/s41598-025-90211-z.
2
A Pilot Study of Exosome Proteomic Profiling Reveals Dysregulated Metabolic Pathways in Endometrial Cancer.一项关于外泌体蛋白质组学分析的初步研究揭示了子宫内膜癌中代谢途径的失调。
Biomedicines. 2025 Jan 3;13(1):95. doi: 10.3390/biomedicines13010095.
3
Immunological Roles of CCL18 in Pan‑Cancer and Its Potential Value in Endometrial Cancer.

本文引用的文献

1
Phospho-DIGE Identified Phosphoproteins Involved in Pathways Related to Tumour Growth in Endometrial Cancer.磷酸化 DIGE 鉴定出与子宫内膜癌肿瘤生长相关通路中的磷酸化蛋白。
Int J Mol Sci. 2023 Jul 26;24(15):11987. doi: 10.3390/ijms241511987.
2
To metabolomics and beyond: a technological portfolio to investigate cancer metabolism.从代谢组学到更广阔的领域:研究癌症代谢的技术组合。
Signal Transduct Target Ther. 2023 Mar 22;8(1):137. doi: 10.1038/s41392-023-01380-0.
3
A Label-Free Proteomic Approach for the Identification of Biomarkers in the Exosome of Endometrial Cancer Serum.
CCL18在泛癌中的免疫作用及其在子宫内膜癌中的潜在价值
Mol Biotechnol. 2025 Jun;67(6):2399-2410. doi: 10.1007/s12033-024-01205-7. Epub 2024 May 30.
4
Transcription Factor STAT3-Activated LDHB Promotes Tumor Properties of Endometrial Cancer Cells by Inducing MDH2 Expression.转录因子STAT3激活的LDHB通过诱导MDH2表达促进子宫内膜癌细胞的肿瘤特性。
Mol Biotechnol. 2025 Feb;67(2):562-574. doi: 10.1007/s12033-024-01067-z. Epub 2024 Feb 21.
一种用于鉴定子宫内膜癌血清外泌体中生物标志物的无标记蛋白质组学方法。
Cancers (Basel). 2022 Dec 19;14(24):6262. doi: 10.3390/cancers14246262.
4
The Regulatory Role of Lipid Metabolism in Endometrial Cancer.脂质代谢在子宫内膜癌中的调节作用
J Oncol. 2022 Aug 29;2022:6458877. doi: 10.1155/2022/6458877. eCollection 2022.
5
Metabolomics biotechnology, applications, and future trends: a systematic review.代谢组学的生物技术、应用及未来趋势:一项系统综述
RSC Adv. 2019 Nov 14;9(64):37245-37257. doi: 10.1039/c9ra06697g. eCollection 2019 Nov 13.
6
Proteomic Analysis of Endometrial Cancer Tissues from Patients with Type 2 Diabetes Mellitus.2型糖尿病患者子宫内膜癌组织的蛋白质组学分析
Life (Basel). 2022 Mar 28;12(4):491. doi: 10.3390/life12040491.
7
Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells.磷脂酰胆碱衍生的脂质介质:癌细胞与免疫细胞的串扰。
Front Immunol. 2022 Feb 15;13:768606. doi: 10.3389/fimmu.2022.768606. eCollection 2022.
8
Identification of New Regulators of Pancreatic Cancer Cell Sensitivity to Oxaliplatin and Cisplatin.鉴定新的调控因子,以提高胰腺癌细胞对奥沙利铂和顺铂的敏感性。
Molecules. 2022 Feb 14;27(4):1289. doi: 10.3390/molecules27041289.
9
Endometrial cancer.子宫内膜癌。
Nat Rev Dis Primers. 2021 Dec 9;7(1):88. doi: 10.1038/s41572-021-00324-8.
10
The role of alternative splicing in human cancer progression.可变剪接在人类癌症进展中的作用。
Am J Cancer Res. 2021 Oct 15;11(10):4642-4667. eCollection 2021.